ReviewJournal of immunotherapy and precision oncology2022

Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review.

Kavanya Feustel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.